Xeomin, Radiesse, and Belotero Facial/Neck Rejuvenational
Part of paid clinical trials in Ardmore, Pennsylvania.
- Sponsor
- Main Line Center for Laser Surgery
- Study ID
- NCT05039723
- Phase
- PHASE4
- Status
- Completed
Conditions
- Photoaging
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Radiesse, Xeomin, Belotero — DRUGRejuvenation with Radiesse, Xeomin, Belotero
Study Details
The purpose of this study is to determine the improvement in signs of photoaging and subject satisfaction after combination, global facial and/or neck treatment with IncobotulinumA (Xeomin), HA (Belotero) and/or calcium hydroxyapatite (Radiesse+, Radiesse Classic). All products will be used on-label FDA-cleared indications.
Key Dates
- Start date
- Sep 1, 2021
- Status verified
- Jul 2022
- Primary completion
- Mar 1, 2022
- Completion
- Jul 1, 2022
Study Design
- Enrollment
- 22 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: TreatmentTreatment with Xeomin, Radiesse, and/or Belotero
Primary Outcome Measure
FACE-Q Subject Satisfaction [ Time Frame: 3 months ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Main Line Center for Laser Surgery | Ardmore | Pennsylvania | 19003 | - |
Find similar trials in Ardmore, PA
By research site
Related Studies
- Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human SkinRecruiting · University of Michigan · Ann Arbor, Michigan